Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Incidence and Characteristics of Clostridioides difficile Infection in Children

소아 Clostridioides difficile 감염의 발생률 및 임상양상

  • Jeong, Heera (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kang, Ji-Man (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Ahn, Jong Gyun (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine)
  • 정희라 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과) ;
  • 강지만 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과) ;
  • 안종균 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과)
  • Received : 2020.08.22
  • Accepted : 2020.10.29
  • Published : 2020.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: We evaluated the incidence and characteristics of Clostridioides difficile infection (CDI) in Korean children. Methods: Medical records of patients aged 2-18 years and diagnosed with CDI at a tertiary hospital between 2009 and 2018 were analyzed. The patients were classified into three CDI groups: community-acquired (CA), community onset-health care facility-associated (CO-HCFA), and healthcare facility onset (HO). Results: The incidence of CDI increased from 1.00 to 10.01 cases per 10,000 admissions from 2009 to 2018 (P<0.001). As compared to the CA group, the HO group had a higher frequency of operation and malignancy as predisposing factors (40.4% vs. 0.0%, P=0.001; and 27.7% vs. 0.0%, P=0.027, respectively), frequency and number of previous antibiotic use (97.9% vs. 31.3%, P<0.001; and 2 vs. 0, P<0.001, respectively), and median postdiagnosis hospital stay (13 vs. 5 days, P=0.008). The CO-HCFA group had a lower median age and higher frequency of malignancy than the CA group (5 vs. 13 years, P=0.012; and 30.8% vs. 0.0%, P=0.030, respectively). As compared to the HO group, the CA group had a higher frequency of abdominal pain and hematochezia (56.3% vs. 10.6%, P=0.001; and 50.0% vs. 10.6%, P=0.002, respectively), inflammatory bowel disease (68.8% vs. 2.1%, P=0.001), and intravenous metronidazole treatment (37.5% vs. 2.1%, P=0.001). Conclusions: With the increasing incidence of pediatric CDI, awareness regarding its epidemiology and clinical characteristics is important to manage nosocomial infections.

목적: 이 연구의 목적은 우리 나라 소아에서 Clostridioides difficile 감염(CDI)의 발생률 및 임상양상을 확인하는 것이다. 방법: 2009년 1월부터 2018년 12월까지 세브란스 어린이병원에 입원한 2세 이상 18세 미만의 환자 중 CDI로 진단된 환자들의 의무기록을 확인하였고 환자를 세 군(community acquired [CA], community onset-health care facility associated [CO-HCFA], and health care facility onset [HO] CDI)으로 나누어 임상양상을 비교하였다. 결과: 2009년부터 2018년까지 CDI유병률은 입원환자 10,000명당 1.00명에서 10.01명까지 증가하였다(P<0.001). HO CDI 군은 CA CDI 군에 비해 수술(40.4% vs. 0.0%, P=0.001)과 악성종양(27.7% vs. 0.0%, P=0.027)이 선행된 경우가 많았고 CDI 진단 전 항생제의 사용 빈도(97.9% vs. 31.3%, P<0.001) 및 항생제 개수의 중앙값이(2 vs. 0, P<0.001) 높았으며 CDI진단 이후 재원일수(13일 vs. 5일, P=0.008) 가 길었다. CO-HCFA 군은 CA CDI 군보다 연령의 중앙값이 낮았고(5세 vs. 13세, P=0.012) 악성종양이 선행된 경우가 많았다(30.8% vs. 0.0%, P=0.030). CA CDI 군은 HO CDI 군에 비해 복통(56.3% vs. 10.6%, P=0.001)과 혈변(50.0% vs. 10.6%, P =0.002)이 동반된 빈도가 높았고, 염증성 장질환이 동반된 경우가 많았으며(68.8% vs. 2.1%, P =0.001), 치료로서 정주 metronidazole을 더 자주 사용하였다(37.5% vs. 2.1%, P =0.001). 결론: 국내 소아의 CDI 발생률이 증가되고 있어 이에 대해 경각심을 가지고 역학과 임상적 특징을 파악하는 것은 병원 감염관리를 위하여 중요하다.

Keywords

References

  1. Burke KE, Lamont JT. Clostridium difficile infection: a worldwide disease. Gut Liver 2014;8:1-6. https://doi.org/10.5009/gnl.2014.8.1.1
  2. Gil JH, Seo JW. Clostridium difficile infections in children. Ewha Med J 2011;34:3-12.
  3. Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis 2016;16:447. https://doi.org/10.1186/s12879-016-1786-6
  4. Heister T, Wolkewitz M, Hehn P, Wolff J, Dettenkofer M, Grundmann H, et al. Costs of hospital-acquired Clostridium difficile infections: an analysis on the effect of time-dependent exposures using routine and surveillance data. Cost Eff Resour Alloc 2019;17:16. https://doi.org/10.1186/s12962-019-0184-5
  5. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:825-34. https://doi.org/10.1056/NEJMoa1408913
  6. Lees EA, Miyajima F, Pirmohamed M, Carrol ED. The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review. Eur J Clin Microbiol Infect Dis 2016;35:1047-57. https://doi.org/10.1007/s10096-016-2639-3
  7. Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Clostridium difficile in children: colonisation and disease. J Infect 2011;63:105-13. https://doi.org/10.1016/j.jinf.2011.05.016
  8. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010;51:2-7. https://doi.org/10.1097/MPG.0b013e3181d29767
  9. Stark PL, Lee A, Parsonage BD. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun 1982;35:895-9. https://doi.org/10.1128/iai.35.3.895-899.1982
  10. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:987-94. https://doi.org/10.1093/cid/ciy149
  11. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466-72. https://doi.org/10.1503/cmaj.1041104
  12. McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2008;5:40-8. https://doi.org/10.1038/ncpgasthep1029
  13. Borali E, De Giacomo C. Clostridium difficile infection in children: a review. J Pediatr Gastroenterol Nutr 2016;63:e130-40. https://doi.org/10.1097/MPG.0000000000001264
  14. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010;16:604-9. https://doi.org/10.3201/eid1604.090680
  15. Byun TJ, Han DS, Ahn SB, Cho HS, Kim TY, Eun CS, et al. Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD). Korean J Gastroenterol 2009;54:13-9. https://doi.org/10.4166/kjg.2009.54.1.13
  16. Lee JH, Lee SY, Kim YS, Park SW, Park SW, Jo SY, et al. The incidence and clinical features of Clostridium difficile infection; single center study. Korean J Gastroenterol 2010;55:175-82. https://doi.org/10.4166/kjg.2010.55.3.175
  17. Kim H, Lee Y, Moon HW, Lim CS, Lee K, Chong Y. Emergence of Clostridium difficile ribotype 027 in Korea. Korean J Lab Med 2011;31:191-6.
  18. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140-5. https://doi.org/10.1086/511798
  19. Kim SJ, Kim H, Kim MS, Koh E, Kim CK, Jeong SH, et al. Evaluation of rapid assay (Tox A/B Quik Chek) for the detection of Clostridium difficile toxins A and B. Korean J Clin Microbiol 2008;11:112-6. https://doi.org/10.5145/KJCM.2008.11.2.112
  20. Song PH, Min JH, Kim YS, Jo SY, Kim EJ, Lee KJ, et al. Rapid and accurate diagnosis of Clostridium difficile infection by real-time polymerase chain reaction. Intest Res 2018;16:109-15. https://doi.org/10.5217/ir.2018.16.1.109
  21. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008;122:1266-70. https://doi.org/10.1542/peds.2008-0469
  22. Kim B, Yang H, Jeong S, Lee K, Kim J, Ko J, et al. Clostridium difficile colitis in childhood: associated antibiotics. Korean J Pediatr Gastroenterol Nutr 2002;5:143-9. https://doi.org/10.5223/kjpgn.2002.5.2.143
  23. Park JH, Kang KJ, Kang YN, Kim AS, Hwang JB. Pseudomembranous colitis in children: experience of a university hospital in Korea. Korean J Pediatr 2010;53:184-9. https://doi.org/10.3345/kjp.2010.53.2.184
  24. Sandora TJ, Fung M, Flaherty K, Helsing L, Scanlon P, Potter-Bynoe G, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011;30:580-4. https://doi.org/10.1097/INF.0b013e31820bfb29
  25. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340-3.
  26. Cho HJ, Ryoo E, Sun YH, Cho KH, Son DW, Tchah H. Epidemiology and clinical characteristics of Clostridium difficile-associated disease in children: comparison between community-and hospital-acquired infections. Korean J Pediatr Gastroenterol Nutr 2010;13:146-53. https://doi.org/10.5223/kjpgn.2010.13.2.146
  27. Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009;154:854-8. https://doi.org/10.1016/j.jpeds.2008.12.039